Provectus Pharmaceuticals, Inc Stock Forecast
Provectus Pharmaceuticals, Inc stock upgraded from Hold/Accumulate to Buy Candidate after Wednesday trading session.
(Updated on Apr 24, 2024)
The Provectus Pharmaceuticals, Inc stock price fell by -0.411% on the last day (Wednesday, 24th Apr 2024) from $0.195 to $0.194. During the last trading day the stock fluctuated 7.68% from a day low at $0.181 to a day high of $0.195. The price has risen in 5 of the last 10 days and is up by 14.32% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -70 thousand shares and in total, 68 thousand shares were bought and sold for approximately $13.14 thousand.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 44.19% during the next 3 months and, with a 90% probability hold a price between $0.230 and $0.361 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
PVCT Signals & Forecast
The Provectus Pharmaceuticals, Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.192 and $0.187. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, March 15, 2024, and so far it has fallen -10.54%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Provectus Pharmaceuticals, Inc stock
On the downside, the stock finds support just below today's level from accumulated volume at $0.180 and $0.170. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Provectus Pharmaceuticals, Inc finds support just below today's level at $0.180. If this is broken, then the next support from accumulated volume will be at $0.170 and $0.169.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0139 between high and low, or 7.68%. For the last week the stock has had daily average volatility of 4.97%.
Our recommended stop-loss: $0.184 (-5.02%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 27 days ago.)
Trading Expectations (PVCT) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect Provectus Pharmaceuticals, Inc to open at $0.190, and during the day (based on 14 day Average True Range), to move between $0.177 and $0.211, which gives a possible trading interval of +/-$0.0169 (+/-8.74%) up or down from last closing price. If Provectus Pharmaceuticals, Inc takes out the full calculated possible swing range there will be an estimated 17.47% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.199 (2.45%) than the support at $0.180 (7.27%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Provectus Pharmaceuticals, Inc stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Provectus Pharmaceuticals, Inc stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.
Current score: 3.685 Buy Candidate Upgraded
Predicted Opening Price for Provectus Pharmaceuticals, Inc of Thursday, April 25, 2024
| Fair opening price April 25, 2024 | Current price |
|---|---|
| $0.190 ( 2.11%) | $0.194 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for PVCT
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.204 | 5.05 % | |
| R2 | 0.198 | 2.31 % | ||
| R1 | 0.195 | 0.624 % | ||
| Current price: | 0.194 | |||
| Support | S1 | 0.185 | -4.85 % | |
| S2 | 0.181 | -6.54 % | ||
| S3 | 0.176 | -9.28 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.213 | 9.90 % | |
| R2 | 0.200 | 3.09 % | ||
| R1 | 0.199 | 2.45 % | ||
| Current price | 0.194 | |||
| Support | S1 | 0.180 | -7.27% | |
| S2 | 0.170 | -12.37% | ||
| S3 | 0.169 | -13.04% |
FAQ
Click here for our free guide on how to buy Provectus Pharmaceuticals, Inc Stock.
